Drugs

Rulemaking History for OTC Benign Prostatic Hypertrophy Drug Products

Final Monographs (21 CFR 310.532):
Drug products containing active ingredients offered over-the-counter (OTC) to relieve the symptoms of benign prostatic hypertrophy
 

Benign Prostatic Hypertrophy Drug Products

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice of Proposed Rulemaking10/1/198247FR43566
Proposed RuleDateFR Citation
Tentative Final Monograph2/20/198752FR5406
    Correction4/14/198752FR12114
    Correction4/30/198752FR15732
Final RuleDateFR Citation
Final Monograph: No GRASE active ingredients2/27/199055FR6926

Page Last Updated: 05/05/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English